MillerKnoll, the renowned furniture company, has announced better-than-expected sales results for the fiscal first quarter. Despite challenging times, the company's resilience shines through as it raises its adjusted earnings outlook for the full year. In addition to this impressive feat, MillerKnoll remains optimistic about the resurgence of back-to-office trends. Investors took notice of this positive news, propelling the company's shares to soar by 17% to $22.32 after-hours.
Cardiff Oncology Achieves Promising Results in Cancer Treatment Trials
In a significant development for the medical community, Cardiff Oncology has unveiled positive data from two trials exploring the use of onvansertib in treating various types of cancer. The company's findings have garnered substantial attention, particularly regarding its trial targeting pancreatic cancer. With such promising results, Cardiff Oncology plans to proceed with a first-line pancreatic investigator-initiated trial. As a result, the company's shares experienced a remarkable 20% surge to $1.95 after hours.
Morphi Holdings CEO Takes Medical Leave of Absence
Morphi Holdings has announced that its Chief Executive, Praveen Tipirneni, will be taking a temporary leave of absence due to an unforeseen medical event. While this news may raise concerns, it is important to note that the company assures there will be no disruptions to its operations during this temporary transition. As soon as Mr. Tipirneni has fully recovered, he will resume his duties as Chief Executive. However, this announcement had a slight impact on investor confidence, causing the company's shares to dip by 7.2% to $19.80.
